Atorvastatin and pitavastatin improve cognitive function and reduce senile plaque and phosphorylated tau in aged APP mice

Alzheimer's Disease Is a Synaptic Failure

Selkoe, D. J. (2002) · Science · doi:10.1126/science.1074069 · Cited by 4,420 · see citing works

Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice

Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210 · see citing works

Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis

Kayed, R., Head, E., Thompson, J. L., McIntire, T. M., Milton, S. C., Cotman, C. W., & Glabe, C. G. (2003) · Science · doi:10.1126/science.1079469 · Cited by 4,064 · see citing works

Diffusible, nonfibrillar ligands derived from Aβ _1–42 are potent central nervous system neurotoxins

Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6448 · Cited by 3,506 · see citing works

Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease

Arriagada, P. V., Growdon, J. H., Hedley-Whyte, E. T., & Hyman, B. T. (1992) · Neurology · doi:10.1212/wnl.42.3.631 · Cited by 2,668 · see citing works

Reducing Endogenous Tau Ameliorates Amyloid ß-Induced Deficits in an Alzheimer's Disease Mouse Model

Roberson, E. D., Scearce-Levie, K., Palop, J. J., Yan, F., Cheng, I. H., Wu, T., Gerstein, H., Yu, G.-Q., & Mucke, L. (2007) · Science · doi:10.1126/science.1141736 · Cited by 1,892 · see citing works

Statins and the risk of dementia

Jick, H., Zornberg, G. L., Jick, S. S., Seshadri, S. S., & Drachman, D. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03155-x · Cited by 1,763 · see citing works

Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors.

Wolozin, B., Kellman, W., Ruosseau, P., Celesia, G., & Siegel, G. (2000) · Archives of Neurology · doi:10.1001/archneur.57.10.1439 · Cited by 1,499 · see citing works

Simvastatin strongly reduces levels of Alzheimer's disease β-amyloid peptides Aβ42 and Aβ40 in vitro and in vivo

Fassbender, K. C., Simons, M., Bergmann, C., Stroick, M., Lütjohann, D., Keller, P., Runz, H., Kühl, S., Bertsch, T., von Bergmann, K., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.081620098 · Cited by 1,078 · see citing works

Age-Dependent Changes in Brain, CSF, and Plasma Amyloid β Protein in the Tg2576 Transgenic Mouse Model of Alzheimer's Disease

Kawarabayashi, T., Younkin, L. H., Saido, T. C., Shoji, M., Ashe, K. H., & Younkin, S. G. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-02-00372.2001 · Cited by 1,053 · cited 1× · see citing works

Hypercholesterolemia Accelerates the Alzheimer's Amyloid Pathology in a Transgenic Mouse Model

Refolo, L. M., Pappolla, M. A., Malester, B., LaFrancois, J. J., Bryant‐Thomas, T., Wang, R., Tint, G. S., Sambamurti, K., & Duff, K. (2000) · Neurobiology of Disease · doi:10.1006/nbdi.2000.0304 · Cited by 1,003 · see citing works

Targeting small Aβ oligomers: the solution to an Alzheimer's disease conundrum?

Klein, W. (2001) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01749-5 · Cited by 989 · see citing works

A Cholesterol-Lowering Drug Reduces β-Amyloid Pathology in a Transgenic Mouse Model of Alzheimer's Disease

Refolo, L. M., Pappolla, M. A., LaFrancois, J. J., Malester, B., Schmidt, S. D., Thomas-Bryant, T., Tint, G. S., Wang, R., Mercken, M. H., Petanceska, S. S., et al. (2001) · Neurobiology of Disease · doi:10.1006/nbdi.2001.0422 · Cited by 521 · see citing works

Alzheimer's disease-type neuronal tau hyperphosphorylation induced by Aβ oligomers

De Felice, F. G., Wu, D., Lambert, M. P., Fernandez, S. J., Velasco, P. T., Lacor, P. N., Bigio, E. H., Jerecic, J., Acton, P. J., Shughrue, P. J., et al. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.02.029 · Cited by 432 · see citing works

A Mouse Model of Amyloid β Oligomers: Their Contribution to Synaptic Alteration, Abnormal Tau Phosphorylation, Glial Activation, and Neuronal Loss <i>In Vivo</i>

Tomiyama, T., Matsuyama, S., Iso, H., Umeda, T., Takuma, H., Ohnishi, K., Ishibashi, K., Teraoka, R., Sakama, N., Yamashita, T., et al. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.5825-09.2010 · Cited by 396 · see citing works

Statin therapy is associated with reduced neuropathologic changes of Alzheimer disease

Li, G., Larson, E. B., Sonnen, J. A., Shofer, J. B., Petrie, E. C., Schantz, A. M., Peskind, E. R., Raskind, M. A., Breitner, J. C. S., & Montine, T. J. (2007) · Neurology · doi:10.1212/01.wnl.0000277657.95487.1c · Cited by 237 · see citing works

3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Inhibitors Attenuate β-Amyloid-Induced Microglial Inflammatory Responses

Cordle, A. C., & Landreth, G. E. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.2544-04.2005 · Cited by 177 · see citing works

Statin therapy for Alzheimer’s disease

Petanceska, S. S., DeRosa, S., Olm, V., Diaz, N. S., Sharma, A., Bryant‐Thomas, T., Duff, K., Pappolla, M. A., & Refolo, L. M. (2002) · Journal of Molecular Neuroscience · doi:10.1007/s12031-002-0026-2 · Cited by 153 · see citing works

Simvastatin enhances learning and memory independent of amyloid load in mice

Li, L., Cao, D., Kim, H., Lester, R. A. J., & Fukuchi, K. (2006) · Annals of Neurology · doi:10.1002/ana.21053 · Cited by 150 · see citing works

Circulating cholesterol levels, apolipoprotein E genotype and dementia severity influence the benefit of atorvastatin treatment in Alzheimer's disease: results of the Alzheimer's Disease Cholesterol-Lowering Treatment (ADCLT) trial

Sparks, D. L., Connor, D. J., Sabbagh, M. N., Petersen, R. B., Lopez, J., & Browne, P. J. (2006) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2006.00690.x · Cited by 130 · see citing works

Simvastatin improves cerebrovascular function and counters soluble amyloid-beta, inflammation and oxidative stress in aged APP mice

Tong, X.-K., Nicolakakis, N., Fernandes, P., Ongali, B., Brouillette, J., Quirion, R., & Hamel, E. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.06.003 · Cited by 122 · see citing works

Statins: Multiple Mechanisms of Action in the Ischemic Brain

Cimino, M., Gelosa, P., Gianella, A., Nobili, E., Tremoli, E., & Sironi, L. (2007) · The Neuroscientist · doi:10.1177/1073858406297121 · Cited by 101 · see citing works

The effects of pitavastatin, eicosapentaenoic acid and combined therapy on platelet-derived microparticles and adiponectin in hyperlipidemic, diabetic patients

Nomura, S., Inami, N., Shouzu, A., Omoto, S., Kimura, Y., Takahashi, N., Tanaka, A., Urase, F., Maeda, Y., Ohtani, H., et al. (2009) · Platelets · doi:10.1080/09537100802409921 · Cited by 98 · see citing works

Effects of Simvastatin on Cerebrospinal Fluid Biomarkers and Cognition in Middle-Aged Adults at Risk for Alzheimer's Disease

Carlsson, C. M., Gleason, C. E., Hess, T., Moreland, K. A., Blazel, H. M., Koscik, R. L., Schreiber, N. T. N., Johnson, S. C., Atwood, C., Puglielli, L., et al. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-13209 · Cited by 92 · see citing works

Statins reduce the neurofibrillary tangle burden in a mouse model of tauopathy

Boimel, M., Grigoriadis, N., Lourbopoulos, A., Touloumi, O., Rosenmann, D., Abramsky, O., & Rosenmann, H. (2009) · Journal of Neuropathology &amp; Experimental Neurology · doi:10.1097/nen.0b013e31819ac3cb · Cited by 86 · see citing works

NK-104: a novel synthetic HMG-CoA reductase inhibitor

Kajinami, K., Mabuchi, H., & Saito, Y. (2000) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.9.11.2653 · Cited by 85 · see citing works

Effects of Lovastatin and Pravastatin on Amyloid Processing and Inflammatory Response in TgCRND8 Brain

Chauhan, N. B., Siegel, G. J., & Feinstein, D. L. (2004) · Neurochemical Research · doi:10.1023/b:nere.0000042217.90204.8d · Cited by 77 · see citing works

Relative Induction of mRNA for HMG CoA Reductase and LDL Receptor by Five Different HMG-CoA Reductase Inhibitors in Cultured Human Cells

Morikawa, S., Umetani, M., Nakagawa, S., Yamazaki, H., Suganami, H., Inoue, K., Kitahara, M., Hamakubo, T., Kodama, T., & Saitō, Y. (2000) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat1994.7.138 · Cited by 76 · see citing works

Long-Term Spatial Cognitive Impairment following Middle Cerebral Artery Occlusion in Rats. A Behavioral Study

Okada, M., Tamura, A., Urae, A., Nakagomi, T., Kirino, T., Mine, K., & Fujiwara, M. (1995) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1995.62 · Cited by 68 · see citing works

Role of GSK‐3β activation and α7 nAChRs in Aβ1–42‐induced tau phosphorylation in PC12 cells

Hu, M., Waring, J. F., Gopalakrishnan, M., & Li, J. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05483.x · Cited by 67 · see citing works

Hypolipidemic effect of NK-104, a potent HMG-CoA reductase inhibitor, in guinea pigs

Suzuki, H., Aoki, T., Tamaki, T., Sato, F., Kitahara, M., & Saitō, Y. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(99)00146-x · Cited by 65 · see citing works

Atorvastatin has distinct effects on endothelial markers in different mouse models of atherosclerosis.

Nachtigal, P., Jamborova, G., Pospisilova, N., Pospěchová, K., Solichová, D., Zdansky, P., & Semecký, V. (2006) · PubMed · Cited by 25 · see citing works

Amyloid-β-independent regulators of tau pathology in Alzheimer disease

van der Kant, R., Goldstein, L. S. B., & Ossenkoppele, R. (2020) · Nature reviews. Neuroscience · doi:10.1038/s41583-019-0240-3 · Cited by 580 · see citing works

Pharmacological Actions of Statins: A Critical Appraisal in the Management of Cancer

Gazzerro, P., Proto, M., Gangemi, G., Malfitano, A. M., Ciaglia, E., Pisanti, S., Santoro, A., Laezza, C., & Bifulco, M. (2011) · Pharmacological Reviews · doi:10.1124/pr.111.004994 · Cited by 458 · see citing works

Cholesterol: its regulation and role in central nervous system disorders

Orth, M., & Bellosta, S. (2012) · Cholesterol · doi:10.1155/2012/292598 · Cited by 339 · see citing works

Role of 4-hydroxy-2-nonenal (HNE) in the pathogenesis of alzheimer disease and other selected age-related neurodegenerative disorders

Di Domenico, F., Tramutola, A., & Butterfield, D. A. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.10.490 · Cited by 253 · see citing works

Systemic lupus erythematosus: updated insights on the pathogenesis, diagnosis, prevention and therapeutics

Dai, X., Fan, Y., & Zhao, X. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02168-0 · Cited by 258 · see citing works

Exercise-Induced Cognitive Plasticity, Implications for Mild Cognitive Impairment and Alzheimer’s Disease

Foster, P. P., Rosenblatt, K. P., & Kuljiš, R. O. (2011) · Frontiers in Neurology · doi:10.3389/fneur.2011.00028 · Cited by 204 · see citing works

Molecular Mechanisms Underlying the Effects of Statins in the Central Nervous System

McFarland, A. J., Anoopkumar‐Dukie, S., Arora, D. S., Grant, G. D., McDermott, C., Perkins, A. V., & Davey, A. K. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms151120607 · Cited by 199 · see citing works

SIRT1 in the brain—connections with aging-associated disorders and lifespan

Ng, F. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00064 · Cited by 185 · see citing works

Gene-environment interactions in Alzheimer's disease: A potential path to precision medicine

Eid, A., Mhatre, I., & Richardson, J. R. (2019) · Pharmacology &amp; Therapeutics · doi:10.1016/j.pharmthera.2019.03.005 · Cited by 164 · see citing works

The relationship between iron dyshomeostasis and amyloidogenesis in Alzheimer's disease: Two sides of the same coin

Peters, D. G., Connor, J. R., & Meadowcroft, M. D. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.08.007 · Cited by 145 · see citing works

Emerging roles for cholesterol in Huntington's disease

Valenza, M., & Cattaneo, E. F. (2011) · Trends in Neurosciences · doi:10.1016/j.tins.2011.06.005 · Cited by 123 · see citing works

Statins and the Brain: More than Lipid Lowering Agents?

Fracassi, A., Marangoni, M., Rosso, P., Pallottini, V., Fioramonti, M., Siteni, S., & Segatto, M. (2018) · Current Neuropharmacology · doi:10.2174/1570159x15666170703101816 · Cited by 116 · see citing works

Is Statin-Associated Cognitive Impairment Clinically Relevant? A Narrative Review and Clinical Recommendations

Rojas‐Fernandez, C. H., & Cameron, J.-C. F. (2012) · Annals of Pharmacotherapy · doi:10.1345/aph.1q620 · Cited by 113 · see citing works

Harnessing endophenotypes and network medicine for Alzheimer's drug repurposing

Fang, J., Pieper, A. A., Nussinov, R., Lee, G., Bekris, L. M., Leverenz, J. B., Cummings, J. L., & Cheng, F. (2020) · Medicinal Research Reviews · doi:10.1002/med.21709 · Cited by 93 · see citing works

Lipid metabolism and neuroinflammation in Alzheimer’s disease: a role for liver X receptors

Kang, J., & Rivest, S. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1049 · Cited by 94 · see citing works

Centella Asiatica Improves Memory and Promotes Antioxidative Signaling in 5XFAD Mice

Matthews, D. G., Caruso, M., Murchison, C. F., Zhu, J. Y., Wright, K. M., Harris, C. J., Gray, N. E., Quinn, J. F., & Soumyanath, A. (2019) · Antioxidants · doi:10.3390/antiox8120630 · Cited by 86 · see citing works

Hypercholesterolemia accelerates intraneuronal accumulation of Aβ oligomers resulting in memory impairment in Alzheimer's disease model mice

Umeda, T., Tomiyama, T., Kitajima, E., Idomoto, T., Nomura, S., Lambert, M. P., Klein, W. L., & Mori, H. (2012) · Life Sciences · doi:10.1016/j.lfs.2011.12.022 · Cited by 78 · see citing works

Statins more than cholesterol lowering agents in Alzheimer disease: Their pleiotropic functions as potential therapeutic targets

Barone, E., Domenico, F. D., & Butterfield, D. A. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.10.030 · Cited by 79 · see citing works

Biliverdin reductase‐A: a novel drug target for atorvastatin in a dog pre‐clinical model of Alzheimer disease

Barone, E., Mancuso, C., Di Domenico, F., Sultana, R., Murphy, M. P., Head, E., & Butterfield, D. A. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07538.x · Cited by 75 · see citing works

The neuroprotective effect of two statins: simvastatin and pravastatin on a streptozotocin-induced model of Alzheimer’s disease in rats

Tramontina, A. C., Wartchow, K. M., Rodrigues, L., Biasibetti, R., Quincozes‐Santos, A., Bobermin, L. D., Tramontina, F. F., & Gonçalves, C. (2011) · Journal of Neural Transmission · doi:10.1007/s00702-011-0680-z · Cited by 72 · see citing works

Apolipoprotein A ‐ I : Insights from redox proteomics for its role in neurodegeneration

Keeney, J. T. R., Swomley, A. M., Förster, S., Harris, J. L., Rukhsana Sultana, A., & Butterfield, D. A. (2012) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201200087 · Cited by 73 · see citing works

Role of Sirtuins and Calorie Restriction in Neuroprotection: Implications in Alzheimers and Parkinsons Diseases

Srivastava, S., & Haigis, M. C. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211798072526 · Cited by 69 · see citing works

A comprehensive review on the lipid and pleiotropic effects of pitavastatin

Sahebkar, A., Kiaie, N., Gorabi, A. M., Mannarino, M. R., Bianconi, V., Jamialahmadi, T., Pirro, M., & Banach, M. (2021) · Progress in Lipid Research · doi:10.1016/j.plipres.2021.101127 · Cited by 68 · see citing works

Pleiotropic effects of statins on brain cells

Sodero, A. O., & Barrantes, F. J. (2020) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2020.183340 · Cited by 66 · see citing works

MicroRNA-208a Increases Myocardial Fibrosis via Endoglin in Volume Overloading Heart

Wang, B. W., Wu, G., Cheng, W.-P., & Shyu, K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0084188 · Cited by 63 · see citing works

Statins and their influence on brain cholesterol

Cibičková, L. (2011) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2011.06.007 · Cited by 58 · see citing works

Eradication ofHelicobacter pyloriIs Associated with the Progression of Dementia: A Population-Based Study

Chang, Y., Chiu, G.-F., Kuo, F., Lai, C., Yang, Y.-H., Hu, H., Chang, P., Chen, C., Wu, D., & Yu, F. (2013) · Gastroenterology Research and Practice · doi:10.1155/2013/175729 · Cited by 54 · see citing works

Chronic Cerebral Hypoperfusion Accelerates Alzheimer’s Disease Pathology with Cerebrovascular Remodeling in a Novel Mouse Model

Zhai, Y., Yamashita, T., Nakano, Y., Sun, Z., Shang, J., Feng, T., Morihara, R., Fukui, Y., Ohta, Y., Hishikawa, N., et al. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160345 · Cited by 54 · see citing works

Atorvastatin and pitavastatin reduce senile plaques and inflammatory responses in a mouse model of Alzheimer’s disease

Kurata, T., Miyazaki, K., Kozuki, M., Morimoto, N., Ohta, Y., Ikeda, Y., & Abe, K. (2012) · Neurological Research · doi:10.1179/1743132812y.0000000054 · Cited by 49 · see citing works

Cholesterol and Alzheimer's disease: A still poorly understood correlation

Ricciarelli, R., Canepa, E., Marengo, B., Marinari, U. M., Poli, G., Pronzato, M. A., & Domenicotti, C. (2012) · IUBMB Life · doi:10.1002/iub.1091 · Cited by 50 · see citing works

Pitavastatin decreases tau levels via the inactivation of Rho/ROCK

Hamano, T., Yen, S.-H., Gendron, T., Ko, L.-W., & Kuriyama, M. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.10.020 · Cited by 49 · see citing works

Neuroprotective effects of statins against amyloid β-induced neurotoxicity

Huang, C., Li, H., & Lin, C. (2018) · Neural Regeneration Research · doi:10.4103/1673-5374.226379 · Cited by 47 · see citing works

Atorvastatin and pitavastatin reduce oxidative stress and improve IR/LDL-R signals in Alzheimer’s disease

Kurata, T., Miyazaki, K., Morimoto, N., Kawai, H., Ohta, Y., Ikeda, Y., & Abe, K. (2013) · Neurological Research · doi:10.1179/1743132812y.0000000127 · Cited by 42 · see citing works

Neurovascular and Cognitive failure in Alzheimer’s Disease: Benefits of Cardiovascular Therapy

Hamel, É., Royea, J., Ongali, B., & Tong, X. (2016) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-015-0285-4 · Cited by 41 · see citing works

Simvastatin enhances the hippocampal klotho in a rat model of streptozotocin-induced cognitive decline

Adeli, S., Zahmatkesh, M., Tavoosidana, G., Karimian, M., & Hassanzadeh, G. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2016.09.009 · Cited by 41 · see citing works

CD55 upregulation in astrocytes by statins as potential therapy for AQP4-IgG seropositive neuromyelitis optica

Tradtrantip, L., Duan, T., Yeaman, M. R., & Verkman, A. S. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1448-x · Cited by 40 · see citing works

The Complex Actions of Statins in Brain and their Relevance for Alzheimer’s Disease Treatment: an Analytical Review

Mendoza‐Oliva, A., Zepeda, A., & Arias, C. (2014) · Current Alzheimer Research · doi:10.2174/1567205011666141001114858 · Cited by 35 · see citing works

Association of Hypercholesterolemia with Alzheimer’s Disease Pathology and Cerebral Amyloid Angiopathy

Xu, C., Apostolova, L. G., Oblak, A. L., & Gao, S. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-191023 · Cited by 35 · see citing works

Atorvastatin and pitavastatin protect cerebellar Purkinje cells in AD model mice and preserve the cytokines MCP-1 and TNF-α

Kozuki, M., Kurata, T., Miyazaki, K., Morimoto, N., Ohta, Y., Ikeda, Y., & Abe, K. (2011) · Brain Research · doi:10.1016/j.brainres.2011.03.024 · Cited by 34 · see citing works

Are microRNAs the Molecular Link Between Metabolic Syndrome and Alzheimer’s Disease?

Codocedo, J. F., Ríos, J. A., Godoy, J. A., & Inestrosa, N. C. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9201-7 · Cited by 34 · see citing works

Examination of the FDA Warning for Statins and Cognitive Dysfunction

Sahebzamani, F. M. (2014) · Journal of Pharmacovigilance · doi:10.4172/2329-6887.1000141 · Cited by 30 · see citing works

Cognitive Enhancers (Nootropics). Part 2: Drugs Interacting with Enzymes

Froestl, W., Muhs, A., & Pfeifer, A. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-121537 · Cited by 31 · see citing works

Statins have therapeutic potential for the treatment of Alzheimer's disease, likely via protection of the neurovascular unit in the AD brain

Kurata, T., Kawai, H., Miyazaki, K., Kozuki, M., Morimoto, N., Ohta, Y., Ikeda, Y., & Abe, K. (2012) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2012.06.011 · Cited by 31 · see citing works

Long-term Effect of Telmisartan on Alzheimer’s Amyloid Genesis in SHR-SR After tMCAO

Kurata, T., Lukic, V., Kozuki, M., Wada, D., Miyazaki, K., Morimoto, N., Ohta, Y., Deguchi, K., Yamashita, T., Hishikawa, N., et al. (2014) · Translational Stroke Research · doi:10.1007/s12975-013-0321-y · Cited by 31 · see citing works

Progressive neurovascular disturbances in the cerebral cortex of Alzheimer's disease-model mice: protection by atorvastatin and pitavastatin

Kurata, T., Miyazaki, K., Kozuki, M., Morimoto, N., Ohta, Y., Ikeda, Y., & Abe, K. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.09.030 · Cited by 30 · see citing works

Selective benefits of simvastatin in bitransgenic APPSwe,Ind/TGF-β1 mice

Papadopoulos, P., Tong, X., & Hamel, É. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.07.010 · Cited by 26 · see citing works

Atorvastatin ameliorates cognitive impairment, Aβ1-42 production and Tau hyperphosphorylation in APP/PS1 transgenic mice

Zhou, D., Liu, H., Li, C., Wang, F., Shi, Y., Liu, L., Zhao, X., Liu, A., Zhang, J., Wang, C., et al. (2016) · Metabolic Brain Disease · doi:10.1007/s11011-016-9803-4 · Cited by 26 · see citing works

Clinical and Pathological Benefit of Twendee X in Alzheimer's Disease Transgenic Mice with Chronic Cerebral Hypoperfusion

Liu, X., Yamashita, T., Shang, J., Shi, X., Morihara, R., Huang, Y. C., Sato, K., Takemoto, M., Hishikawa, N., Ohta, Y., et al. (2019) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2019.03.029 · Cited by 25 · see citing works

Effect of Atorvastatin and Rosuvastatin on Learning and Memory in Rats with Diazepam-Induced Amnesia

Georgieva-Kotetarova, M., & Kostadinova, I. I. (2013) · Folia Medica · doi:10.2478/folmed-2013-0018 · Cited by 24 · see citing works

Bryostatin-1 vs. TPPB: Dose-Dependent APP Processing and PKC-α, -δ, and -ε Isoform Activation in SH-SY5Y Neuronal Cells

Yi, P., Schrott, L. M., Castor, T. P., & Alexander, J. (2012) · Journal of Molecular Neuroscience · doi:10.1007/s12031-012-9816-3 · Cited by 24 · see citing works

Association of Cognitive Impairment in Patients on 3-Hydroxy-3-Methyl-Glutaryl-CoA Reductase Inhibitors

Roy, S., Weinstock, J. L., Ishino, A. S., Benites, J., Pop, S. R., Perez, C., Gumbs, E. A., Rosenbaum, J. A., Roccato, M. K., Shah, H., et al. (2017) · Journal of Clinical Medicine Research · doi:10.14740/jocmr3066w · Cited by 22 · see citing works

Statins Reduce Amyloid β-Peptide Production by Modulating Amyloid Precursor Protein Maturation and Phosphorylation Through a Cholesterol-Independent Mechanism in Cultured Neurons

Hosaka, A., Araki, W., Oda, A., Tomidokoro, Y., & Tamaoka, A. (2012) · Neurochemical Research · doi:10.1007/s11064-012-0956-1 · Cited by 22 · see citing works

Effects of HMG-CoA reductase inhibitors on learning and memory in the guinea pig

Maggo, S. D. S., & Ashton, J. C. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.11.018 · Cited by 21 · see citing works

Oatp1a4 and an L-Thyroxine-Sensitive Transporter Mediate the Mouse Blood-Brain Barrier Transport of Amyloid-β Peptide

Minh, T. N., Bedussi, B., Chasseigneaux, S., Dodacki, A., Yapo, C., Chacun, H., Scherrmann, J., Farinotti, R., & Bourasset, F. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-121891 · Cited by 20 · see citing works

Cognitive Function Assessment in Patients on Moderate- or High-Intensity Statin Therapy

Roy, S., Hyman, D., Ayyala, S., Bakhshi, A., Kim, S. H., Anoruo, N., Weinstock, J. L., Balogun, A., D’Souza, M., Filatova, N., et al. (2020) · Journal of Clinical Medicine Research · doi:10.14740/jocmr4144 · Cited by 18 · see citing works

Alzheimer’s Disease, Obesity, and Type 2 Diabetes: Focus on Common Neuroglial Dysfunctions (Critical Review and New Data on Human Brain and Models)

Tolédano, A., Rodríguez‐Casado, A., Álvarez, M., & Toledano‐Díaz, A. (2024) · Brain Sciences · doi:10.3390/brainsci14111101 · Cited by 19 · see citing works

Nitric oxide involvement in consolidation, but not retrieval phase of cognitive performance enhanced by atorvastatin in mice

Rayatnia, F., Paydar, M. J., Allami, N., Zakeri, M., Rastegar, H., Norouzi, A., & Dehpour, A. R. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.05.017 · Cited by 17 · see citing works

Atorvastatin stimulates neuroblastoma cells to induce neurite outgrowth by increasing cellular prion protein expression

Watanabe, T., Yasutaka, Y., Nishioku, T., Nakashima, A., Futagami, K., Yamauchi, A., & Kataoka, Y. (2012) · Neuroscience Letters · doi:10.1016/j.neulet.2012.10.032 · Cited by 17 · see citing works

Atorvastatin prevents Aβ oligomer-induced neurotoxicity in cultured rat hippocampal neurons by inhibiting Tau cleavage

Sui, H., Zhang, L., Liu, Z., & Jin, Y. (2015) · Acta Pharmacologica Sinica · doi:10.1038/aps.2014.161 · Cited by 17 · see citing works

Coenzyme Q10 and cognition in atorvastatin treated dogs

Martin, S. B., Cenini, G., Barone, E., Dowling, A. L. S., Mancuso, C., Butterfield, D. A., Murphy, M. P., & Head, E. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.06.054 · Cited by 16 · see citing works

Clinical and Pathological Benefits of Edaravone for Alzheimer’s Disease with Chronic Cerebral Hypoperfusion in a Novel Mouse Model

Feng, T., Yamashita, T., Shang, J., Shi, X., Nakano, Y., Morihara, R., Tsunoda, K., Nomura, E., Sasaki, R., Tadokoro, K., et al. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190369 · Cited by 15 · see citing works

Effects of Walnut Polyphenol on Learning and Memory Functions in Hypercholesterolemia Mice

Shi, D., Chen, C., Zhao, S., Ge, F., Liu, D., & Song, H. (2014) · Journal of Food and Nutrition Research · doi:10.12691/jfnr-2-8-4 · Cited by 15 · see citing works

Protective Effect of Rivaroxaban Against Amyloid Pathology and Neuroinflammation Through Inhibiting PAR-1 and PAR-2 in Alzheimer’s Disease Mice

Bian, Z., Liu, X., Feng, T., Yu, H., Hu, X. F., Hu, X., Bian, Y., Sun, H., Tadokoro, K., Takemoto, M., et al. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-215318 · Cited by 14 · see citing works

The calcium-free form of atorvastatin inhibits amyloid-β(1–42) aggregation in vitro

Nedaei, H., Rezaei‐Ghaleh, N., Giller, K., Becker, S., Karami, L., Moosavi‐Movahedi, A. A., Griesinger, C., & Moosavi‐Movahedi, A. A. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.101662 · Cited by 14 · see citing works

Angiotensin-converting enzyme inhibitors and statins therapies-induced changes in omics profiles in humans and transgenic tau mice

Collu, R., Giunti, E., Daley, S. A., Chen, M., & Xia, W. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115756 · Cited by 14 · see citing works

Involvement of H2S, NO and BDNF‐TrkB signalling pathway in the protective effects of simvastatin against pentylenetetrazole‐induced kindling and cognitive impairments in mice

Ahmed, M. A., & Kamel, E. O. (2020) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13457 · Cited by 12 · see citing works

Prostaglandin A1 Inhibits the Cognitive Decline of APP/PS1 Transgenic Mice via PPARγ/ABCA1-dependent Cholesterol Efflux Mechanisms

Xu, G., Yang, L., Guan, P.-P., Wang, Z., & Wang, P. (2019) · Neurotherapeutics · doi:10.1007/s13311-018-00704-1 · Cited by 12 · see citing works

Pitavastatin protects against neomycin-induced ototoxicity through inhibition of endoplasmic reticulum stress

Wu, Y., Meng, W., Guan, M., Zhao, X., Zhang, C., Fang, Q., Zhang, Y., Sun, Z., Cai, M., Huang, D., et al. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.963083 · Cited by 12 · see citing works

Biliverdin Reductase-A correlates with inducible nitric oxide synthasein in atorvastatin treated aged canine brain.

Domenico, F. D., Marzia Perluigi, A., & Barone, E. (2013) · PubMed Central · doi:10.3969/j.issn.1673-5374.2013.21.001 · Cited by 11 · see citing works

Impact on Cognitive Function—Are All Statins the Same?

Shah, N. P., Swiger, K. J., & Martin, S. S. (2014) · Current Atherosclerosis Reports · doi:10.1007/s11883-014-0466-5 · Cited by 10 · see citing works

A combination of indomethacin and atorvastatin ameliorates cognitive and pathological deterioration in PrP-hAβPPswe/PS1ΔE9 transgenic mice

Wang, J., Cheng, X., Zhang, X., Liu, G., Wang, Y., Zhou, W., & Zhang, Y. (2019) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2019.03.003 · Cited by 8 · see citing works

Protective Effects Against Dementia Undergo Different Statin Type, Intensity, and Cumulative Dose in Older Adult Type 2 Diabetes Mellitus Patients

Sun, M., Chen, W., Wu, S., & Zhang, J. (2023) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2023.11.010 · Cited by 7 · see citing works

Suppression of memory acquisition following co-administration of lithium and atorvastatin through nitric oxide pathway in mice

Honarmand, A. R., Pourtabatabaei, N., Rahimi, N., Dehpour, A. R., & Paydar, M. J. (2014) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2014.03.023 · Cited by 7 · see citing works

Statin Therapy and the Development of Cerebral Amyloid Angiopathy—A Rodent in Vivo Approach

Reuter, B., Venus, A., Grudzenski, S., Heiler, P. M., Schad, L. R., Staufenbiel, M., Hennerici, M. G., & Fatar, M. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17010126 · Cited by 7 · see citing works

Protective Effects of Statins against Alzheimer Disease

Rezakhani, L., Salimi, Z., Zarei, F., Moradpour, F., Khazaei, M. R., Khazaei, M., & Pourjalili, M. (2023) · Ewha Medical Journal · doi:10.12771/emj.2023.e17 · Cited by 6 · see citing works

Artificial Intelligence based Modern Approaches to Diagnose Alzheimer s

Pai, R. V., & Wadhwa, A. (2022) · Indian Journal of Artificial Intelligence and Neural Networking · doi:10.54105/ijainn.b1045.022222 · Cited by 5 · see citing works

Clinical and Pathological Benefits of Scallop-Derived Plasmalogen in a Novel Mouse Model of Alzheimer’s Disease with Chronic Cerebral Hypoperfusion

Feng, T., Hu, X., Fukui, Y., Bian, Z., Bian, Y., Sun, H., Takemoto, M., Yunoki, T., Nakano, Y., Morihara, R., et al. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-215246 · Cited by 5 · see citing works

Tocovid Attenuated Oxidative Stress and Cognitive Decline by Inhibiting Amyloid-β-Induced NOX2 Activation in Alzheimer’s Disease Mice

Bian, Z., Yu, H., Hu, X., Bian, Y., Sun, H., Tadokoro, K., Takemoto, M., Yunoki, T., Nakano, Y., Fukui, Y., et al. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220761 · Cited by 4 · see citing works

Statins - From Lipid-Lowering Benefits to Pleiotropic Effects

Liu, D. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.1001540 · Cited by 4 · see citing works

Role of Pomegranate Juice and Atorvastatin in Ameliorating Spinal Neurotoxicity of Wistar Rats Maternally Fed on Hypercholesterolemic Diet

El‐Sayyad, H. I., Amin, A. H., Ghawet, H. A. E., Al-Shahari, E. E., & Gebaly, A. E. (2016) · Journal of Molecular Biomarkers & Diagnosis · doi:10.4172/2155-9929.1000316 · Cited by 4 · see citing works

Atorvastatin enhances kainate‐induced gamma oscillations in rat hippocampal slices

Li, C., Wang, J., Zhao, J., Wang, Y., Liu, Z., Guo, F. L., Wang, X. F., Vreugdenhil, M., & Lu, C. B. (2016) · European Journal of Neuroscience · doi:10.1111/ejn.13322 · Cited by 4 · see citing works

Statins and Reduction of Oxidative Stress in the Aged Brain

Kurata, T., Deguchi, K., Deguchi, S., Ikeda, Y., & Abe, K. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-407824-6.00069-0 · Cited by 2 · see citing works

Statin Use, Ageing, and Cognition: A Review

Stephenson, N. E., & Crowe, S. F. (2016) · Australian Psychologist · doi:10.1111/ap.12116 · Cited by 3 · see citing works

Impact of statins on mortality and disease progression in patients with Alzheimer’s disease: a nationwide cohort study

Park, Y., Lee, H. W., Ye, B. S., Kim, S. Y., & Yu, Y. M. (2025) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2025.101218 · Cited by 2 · see citing works

Role of centrally active cardiovascular agents in cognitive disorders

Theobald, R. J. (2017) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2017.05.001 · Cited by 2 · see citing works

Spearmint extract Neumentix downregulates amyloid-β accumulation by promoting phagocytosis in APP23 mice

Hu, X., Morihara, R., Fukui, Y., Bian, Y., Sun, H., Ota-Elliott, R. S., Ishiura, H., Abe, K., & Yamashita, T. (2025) · Brain Research · doi:10.1016/j.brainres.2025.149752 · Cited by 1 · see citing works

Protective effects of Dendrobium nobile Lindl. alkaloids in a novel mouse model of Alzheimer's disease with chronic cerebral hypoperfusion

Feng, T., Chen, W., Bian, Z., Sun, H., & Shen, L. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251406645 · Cited by 1 · see citing works

A physics-informed graph neural network to approximate docking-based binding affinity for DYRK2 in Alzheimer’s drug repurposing

Gider, V., & Budak, C. (2026) · Scientific Reports · doi:10.1038/s41598-026-35102-7 · Cited by 1 · see citing works

Editorial Commentary: Are statins a solution to reduce the risk of cognitive decline or lower the risk of dementia?

Golive, A., & Bunch, T. J. (2016) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2016.04.008 · Cited by 1 · see citing works

Guidelines for the treatment of dementia

Kurata, T., & Abe, K. (2014) · Okayama Igakkai Zasshi (Journal of Okayama Medical Association) · doi:10.4044/joma.126.155

Controversies over Statins-related Cognitive Impairment

INGOLE, S. A., Jain, R., & Tamboli, T. J. (2016) · International Journal of Cardiovascular and Cerebrovascular Disease · doi:10.13189/ijccd.2016.040202

A study of the global effects of Apolipoprotein E using lipidomics

Hawksworth, J. I. (2019) · ORCA Online Research @Cardiff (Cardiff University)

Statins’ Effects on Alzheimer’s Disease

Li, Q., Li, C.-N., & Chen, J. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.1001286

Behavioral and Metabolic Effects of ABCG4 KO in the APPswe,Ind (J9) Mouse Model of Alzheimer’s Disease

Fong, V., Kanuri, B., Traubert, O. D., Lui, M., & Patel, S. B. (2024) · Journal of Molecular Neuroscience · doi:10.1007/s12031-024-02214-6

Statins as Neuroinflammatory Therapy, Bibliometric Study

Saleh, A. Y., Susanto, T. D., Valentina, R., & Saputra, D. A. Y. (2024) · F1000Research · doi:10.12688/f1000research.152963.1

Intégrité de la barrière hémato-encéphalique et transport du peptide bêta-amyloïde dans la maladie d'Alzheimer

Do, T. M. (2012) · theses.fr (ABES) · doi:10.70675/39078922z7524z4044z80dcz166165217d2b

Caractérisation du site de liaison du cholestérol sur l'APP : un modulateur de la sécrétion de peptides amyloïdes

Hanbouch, L. (2017) · theses.fr (ABES) · doi:10.70675/c4d2c894zf69dz4ae4z9ab1zf4135d0efa12

Clusterin regulates microglial inflammation and cognitive function independent of amyloid pathology in Alzheimer’s diseasePreprint

Rawal, P., Moon, H.-J., Nguyen, V., Khatri, S., Larson, M. A., Vivian, J. C., Saido, T. C., & Zhao, L. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.07.30.741791

P3‐056: Atorvastatin and pitavastatin improve cognitive function and reduce senile plaque and phosphorylated tau in aged APP mice

Abe, K., Kurata, T., Miyazaki, K., Kozuki, M., Morimoto, N., Ohta, Y., Ikeda, Y., & Matsuura, T. (2011) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2011.05.1495

P1‐248: Atorvastatin and pitavastatin reduce senile plaques and inflammatory responses in model mice with Alzheimer's disease

Kurata, T., Miyazaki, K., Kozuki, M., Morimoto, N., Matsuzono, K., Ohta, Y., Ikeda, Y., & Abe, K. (2012) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2012.05.527 · Cited by 1 · see citing works

Atorvastatin and pitavastatin reduce senile plaques and inflammatory responses in a mouse model of Alzheimer’s disease

Kurata, T., Miyazaki, K., Kozuki, M., Morimoto, N., Ohta, Y., Ikeda, Y., & Abe, K. (2012) · Neurological Research · doi:10.1179/1743132812y.0000000054 · Cited by 49 · see citing works

Atorvastatin and pitavastatin reduce oxidative stress and improve IR/LDL-R signals in Alzheimer’s disease

Kurata, T., Miyazaki, K., Morimoto, N., Kawai, H., Ohta, Y., Ikeda, Y., & Abe, K. (2013) · Neurological Research · doi:10.1179/1743132812y.0000000127 · Cited by 42 · see citing works

Statins have therapeutic potential for the treatment of Alzheimer's disease, likely via protection of the neurovascular unit in the AD brain

Kurata, T., Kawai, H., Miyazaki, K., Kozuki, M., Morimoto, N., Ohta, Y., Ikeda, Y., & Abe, K. (2012) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2012.06.011 · Cited by 31 · see citing works